Neurobehavioral Biomarkers: An EEG Family Reunion
- PMID: 34366398
- PMCID: PMC8810913
- DOI: 10.1097/WNP.0000000000000836
Neurobehavioral Biomarkers: An EEG Family Reunion
Abstract
The field of clinical EEG has had an uneasy relationship with the use of this technology for clinical cognitive applications and often for good reason. However, apart from its clinical use, EEG has had a tradition as a major tool in cognitive psychology and cognitive neuroscience dating back at least to the 1960s. Based on accumulated knowledge from its research application, EEG-based biomarkers are beginning to see applications in clinical trials and may eventually enter clinical care. We address concerns surrounding quality control, the treatment of artifact, and normal variants and how developments in engineering, biomarker validation, and implementation science rigorously applied to these tools can lead to well-justified approaches.
Copyright © 2021 by the American Clinical Neurophysiology Society.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
References
-
- Nuwer M Assessment of digital EEG, quantitative EEG, and EEG brain mapping: report of the American Academy of Neurology and the American Clinical Neurophysiology Society. Neurology. 1997. Jul;49(1):277–92. - PubMed
-
- Ewen JB. The eternal promise of EEG-based biomarkers: Getting closer? Neurology. 2016. Nov 29;87(22):2288–9. - PubMed
-
- Berger H On the Electroencephalogram of Man: Twelfth Report. Electroencep clin Neurophysiol 1969;Suppl. 28:267–87. - PubMed
-
- Gloor P Hans Berger and the discovery of the electroencephalogram. Electroencep clin Neurophysiol 1969;Suppl. 28:1–36. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
